Clinical trial
Clonidine for Neurocognitive Sequelae
NCT00166686 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Withdrawn
Key facts
| NCT number | NCT00166686 |
|---|---|
| Title | Clonidine for Neurocognitive Sequelae |
| Official title | Clonidine for the Treatment of Neurocognitive Sequelae Following Cancer Treatment in Children |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Treatment-Related Cancer |
| Intervention type | Drug |
| Interventions | Clonidine |
| Enrollment | 0 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: